Year |
Citation |
Score |
2021 |
Park UC, Park SS, Kim BH, Park SW, Kim YJ, Cary W, Anderson JD, Nolta JA, Yu HG. Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration. Annals of Translational Medicine. 9: 1275. PMID 34532412 DOI: 10.21037/atm-20-4662 |
0.54 |
|
2021 |
Cheung KW, Yazdanyar A, Dolf C, Cary W, Marsh-Armstrong N, Nolta JA, Park SS. Analysis of the retinal capillary plexus layers in a murine model with diabetic retinopathy: effect of intravitreal injection of human CD34 bone marrow stem cells. Annals of Translational Medicine. 9: 1273. PMID 34532410 DOI: 10.21037/atm-20-3930 |
0.374 |
|
2019 |
Yazdanyar A, Zhang P, Dolf C, Smit-McBride Z, Cary W, Nolta JA, Zawadzki RJ, Marsh-Armstrong N, Park SS. Effects of intravitreal injection of human CD34 bone marrow stem cells in a murine model of diabetic retinopathy. Experimental Eye Research. 107865. PMID 31682846 DOI: 10.1016/J.Exer.2019.107865 |
0.351 |
|
2019 |
Singh MS, Park SS, Albini TA, Canto-Soler MV, Klassen H, MacLaren RE, Takahashi M, Nagiel A, Schwartz SD, Bharti K. Retinal stem cell transplantation: Balancing safety and potential. Progress in Retinal and Eye Research. 100779. PMID 31494256 DOI: 10.1016/J.Preteyeres.2019.100779 |
0.375 |
|
2017 |
Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Current Eye Research. 1-10. PMID 28636406 DOI: 10.1080/02713683.2017.1319491 |
0.533 |
|
2016 |
Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA. Advances in bone marrow stem cell therapy for retinal dysfunction. Progress in Retinal and Eye Research. PMID 27784628 DOI: 10.1016/J.Preteyeres.2016.10.002 |
0.556 |
|
2016 |
Moisseiev E, Smit-McBride Z, Oltjen S, Zhang P, Zawadzki RJ, Motta M, Murphy CJ, Cary W, Annett G, Nolta JA, Park SS. Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration. Investigative Ophthalmology & Visual Science. 57: 4125-4135. PMID 27537262 DOI: 10.1167/Iovs.16-19252 |
0.416 |
|
2016 |
Park SS. Cell Therapy Applications for Retinal Vascular Diseases: Diabetic Retinopathy and Retinal Vein Occlusion. Investigative Ophthalmology & Visual Science. 57: ORSFj1-ORSFj10. PMID 27116667 DOI: 10.1167/iovs.15-17594 |
0.411 |
|
2015 |
Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Investigative Ophthalmology & Visual Science. 56: 81-9. PMID 25491299 DOI: 10.1167/Iovs.14-15415 |
0.362 |
|
Show low-probability matches. |